Labcorp Clinical Research LP

Dallas, Texas 75247

0 studies enrolling now · 4 studies all time

What they study most

Healthy, Obese

Studies at this site

• A Multiple Dose Study of LY3502970 in Healthy Overweight and Obese Participants — Completed
• A Drug Drug Interaction (DDI) Study of Selpercatinib (LY3527723) and Rosuvastatin in Healthy Participants — Completed
• A Bioequivalence Study of Mirikizumab (LY3074828) Solution in Healthy Participants — Completed
• A Bioequivalence Study of Mirikizumab (LY3074828) in Healthy Participants — Completed